Approves

FDA Approves Human Hookworm Vaccine for Phase I Safety Trials

As any dedicated video game player knows, the first requireme...

FDA Approves New Drug to Treat Type I and Type II Diabetes

The Food and Drug Administration (FDA) today approved Symlin, an injectable medicine to control blood sugar for adults with type 1 and type 2 diabetes. Symlin is to be used in addition to insulin therapy in patients who cannot achieve adequate control of their blood sugars on intensive insulin therapy alone. Symlin will be the only therapy for the treatment of type 1 diabetes other than in...

Canada approves marijuana-based pain spray

Health Canada has approved Sativex® (Cannabis sativa L. extract) a new drug developed as adjunctive treatment for the symptomatic relief of neuropathic pain in adults with multiple sclerosis (MS). Canada becomes the first country in the world to approve Sativex, a novel prescription pharmaceutical product derived from components of the cannabis plant shown to have therapeutic properties. Sativex...

FDA Approves New Treatment for Chronic Hepatitis B

The Food and Drug Administration (FDA) announced the approval of Baraclude (entecavir) tablets and oral solution for the treatment of chronic hepatitis B in adults. Chronic hepatitis B is a serious disease caused by the hepatitis B virus (HBV) that attacks the liver. The virus can cause lifelong infection, cirrhosis (scarring) of the liver, liver cancer, liver failure, and death. According to the...

FDA approves more generic AIDS drugs

Experimenting with Arabidopsis, a fast-growing cousin of the humble mustard plant, scientists at the University of North Carolina at Chapel Hill got a big surprise while investigating how plants respond to attacks from disease organisms such as bacteria and viruses. "Contrary to what we thought we'd find, our experiments showed that at least three different proteins work in concert with on...

More>>

Approves at Biology Products

No data found

Search Approves biology products at Google

Search Approves biology products at Yahoo

Search Approves biology products at Msn

Approves at Biology Technology

FDA approves Bone Cares Hectorol for treatment of kidney disease

Middleton, Wis. -- announced Monday the U.S. Food and Drug Administration approved a new indication and strength for Hectorol (doxercalciferol) Capsules. Hectorol, a pro-hormone vitamin D2 analog, is currently approved for the treatment of secondary hyperparathyroidism (SHPT) in dialysis patients in the United Sta...

UW-Madison approves new research institute

The institute is a collaboration of the four UW-Madison health sciences schools: Medicine and Public Health, Nursing, Pharmacy, an...

FDA approves GE's heart-imaging technology

The technology is based on compu...

Senate approves bill to expand stem cell funding

The measure fell short of the 67 votes needed to override a veto, which would be the first veto of th...

FDA approves advanced digital mammography system

The system offers more evidence that the medical community is moving to adopt digital mammography tools that enable higher quality images for the detection of breast cancer. With...

More>>

Approves at Medicine News

FDA approves Watson Pharmaceuticals' Oxytrol patch

The Food and Drug Administration has approved a new patch developed by Watson Pharmaceuticals Inc., for the treatment of an overactive bladder. The patch called Oxytrol (generic: oxybutynin transdermal system) reduces urinary urge incontinence, urinary urgency, and urinary frequency, according to the drug's maker. Oral forms of oxybutynin has been around for around 25 years but it has not...

FDA Approves Contraceptive Ring

The U.S. Food and Drug Administration has approved the first hormone-releasing contraceptive implant. NuvaRing, sold by Organon, Inc., effectively blocks conception between 98 percent and 99 percent of the time -- meaning that for every 100 women who use it for a year, only one or two will become pregnant, the FDA says. That rate is similar to both the birth control pill and the yet-unapp...

FDA approves new device to treat women's bleeding disorder

The government has approved a new method to treat women suffering excessive menstrual bleeding, a device that uses radio waves to zap the tissue at fault. Millions of women suffer menorrhagia, benign but troubling menstrual bleeding so excessive they can require more than 20 tampons in a single day. Thousands of women every year get hysterectomies to cure menorrhagia, while other women tr...

FDA Approves New HIV Drug, Viread

Biopharmaceutical firm Gilead Sciences Inc. said it has received approval from the US Food and Drug Administration (FDA) to market its antiretroviral agent Viread (tenofovir disoproxil fumarate) for the treatment of HIV in combination with other antiretroviral agents. Like Viread, such drugs work by blocking the process needed for HIV replication in the body. But Viread is the first nu...

FDA Approves Birth Control Skin Patch

For the first time, the US Food and Drug Administration (FDA) has approved a contraceptive skin patch for weekly use. Ortho Evra, made by New Jersey-based Johnson & Johnson, is a one-and-three-quarter-inch patch containing the hormones norelgestromin and ethinyl estradiol, designed to be an alternative to birth control pills. // The patch delivers the hormones through the skin for a 1...

More>>

Approves at Medicine Products

No data found

Search Approves medicine products at Google

Search Approves medicine products at Yahoo

Search Approves medicine products at Msn

Approves at Medicine Technology

FDA approves MyocondaR IND for MAP in Crohn's Disease

SYDNEY, Australia 24 April 2007. Giaconda Ltd (ASX: GIA) todayannounced that the US Food and Drug Administration (FDA) hasapproved the Company's Investigational New Drug application (IND)for the clinical development of MyocondaR to treat patients withCrohn's Disease infected with Mycobacterium avium sppparatuberculosis (MAP). The Company understands that its lead product, Myocon...

FDA approves IND on Lead Product M6G

CAMBRIDGE, England, 26th April 2007 - CeNeS Pharmaceuticals plc(LSE: CEN), the Cambridge based biopharmaceutical company, todayannounces that the United States Food and Drug Administration (FDA)has approved its Investigational New Drug (IND) application for theclinical development of morphine-6-glucuronide (M6G), its noveldrug for the treatment of post-operative pain. Earlier this year,C...